- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07579572
Serratus Posterior Superior Intercostal Plane Block in Port Catheter Implantation
Comparison of Serratus Posterior Superior Intercostal Plane Block and Local Infiltration for Analgesia During Port Catheter Implantation: A Prospective Randomized Study
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This prospective, randomized controlled study evaluates the analgesic efficacy of the serratus posterior superior intercostal plane (SPSIP) block compared with standard local anesthetic infiltration in patients undergoing port catheter implantation. Although the procedure is usually performed under local anesthesia, patients may experience significant pain during port pocket creation.
Participants will be randomized in a 1:1 ratio to receive either ultrasound-guided SPSIP block or local anesthetic infiltration. All patients will receive standardized monitoring and premedication. Pain intensity during different procedural stages, postoperative pain scores, analgesic consumption, and satisfaction levels will be assessed.
The study aims to determine whether SPSIP block improves intraoperative analgesia and reduces analgesic requirements compared to local infiltration.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Outside of the US
-
Diyarbakır, Outside of the US, Turquie (Türkiye), 21070
- Fatma Acil
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 18-75 years
- ASA physical status I-III
- Scheduled for elective port catheter implantation
- Ability to understand and use the Numeric Rating Scale (NRS)
- Provided written informed consent
Exclusion Criteria:
- Known allergy to local anesthetics
- Infection at the injection site
- Coagulopathy or anticoagulant therapy
- Severe pulmonary disease
- G6PD deficiency
- Pregnancy or breastfeeding
- Inability to assess pain or communicate effectively
- Refusal to participate
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Local Infiltration
Participants will receive standard local anesthetic infiltration during port catheter implantation.
|
Standard local anesthetic infiltration performed at the surgical site during port catheter implantation.
|
|
Expérimental: Serratus Posterior Superior Intercostal Plane Block
Participants will receive an ultrasound-guided SPSIP block prior to port catheter implantation.
|
Ultrasound-guided Serratus Posterior Superior Intercostal plane block performed prior to the procedure.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pain intensity during port pocket creation
Délai: During procedure
|
Pain intensity during port pocket creation measured using the Numeric Rating Scale (0-10), where higher scores indicate greater pain. Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain. |
During procedure
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Maximum intraoperative pain score
Délai: During the procedure
|
The highest pain intensity recorded during any procedural stage will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate greater pain intensity.
|
During the procedure
|
|
Pain intensity during procedural stages
Délai: During the procedure
|
Pain intensity will be assessed during skin puncture, catheter tunneling, and skin closure using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate greater pain intensity.
|
During the procedure
|
|
Total supplemental local anesthetic amount
Délai: During the procedure
|
Total amount of additional local anesthetic administered during the procedure will be recorded in milliliters.
|
During the procedure
|
|
Postoperative pain scores
Délai: 0, 2, 6, 12, and 24 hours after the procedure
|
Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS; 0-10), where 0 indicates no pain and 10 indicates the worst imaginable pain.
Higher scores indicate greater pain intensity.
|
0, 2, 6, 12, and 24 hours after the procedure
|
|
Total tramadol consumption
Délai: Within 24 hours after the procedure
|
Total intravenous tramadol consumption within the first 24 hours after the procedure will be recorded in milligrams.
|
Within 24 hours after the procedure
|
|
Duration of effective analgesia
Délai: Within 24 hours after the procedure
|
Duration of effective analgesia will be defined as the time interval from completion of the procedure to the first administration of rescue analgesia.
|
Within 24 hours after the procedure
|
|
Patient satisfaction score
Délai: After the procedure
|
Patient satisfaction will be assessed using a 5-point Likert scale, where 1 indicates very dissatisfied and 5 indicates very satisfied.
Higher scores indicate greater satisfaction.
|
After the procedure
|
|
Surgeon satisfaction score
Délai: After the procedure
|
Surgeon satisfaction will be assessed using a 5-point Likert scale, where 1 indicates very dissatisfied and 5 indicates very satisfied.
Higher scores indicate greater satisfaction.
|
After the procedure
|
|
Procedure-related complications
Délai: During and within 24 hours after the procedure
|
Procedure-related complications, including pneumothorax, hematoma, local anesthetic systemic toxicity, methemoglobinemia, and infection, will be recorded.
|
During and within 24 hours after the procedure
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Fatma Acil, M.D., Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 07/04/2026-123
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .